Financial Health Scores: Healthcare

Top Healthcare companies by financial health score. Each score is a 0-100 composite of six dimensions ranked as percentiles within the company's peer group (banks against banks, REITs against REITs), so it measures standing among peers rather than absolute cross-industry strength.

Rates the quality of the business, not whether the stock is cheap. A 0–100 composite of profitability, growth, leverage, liquidity, cash flow, and returns.

A high score means strong fundamentals, but not a guaranteed good trade. A great business can still be a bad buy at the wrong price.

Banks, REITs, insurers, and early-stage companies are scored on sector-tailored metrics. The list covers companies worth at least $500 million that are still trading. Full methodology →

Research tool, not financial advice. Use alongside valuation analysis and your own view of the business.

Data as of FY 2025 100 companies Rhea AI

# Company Dimensions

UTHR United Therapeutics Co… 88 Profit Growth Debt Cash Flow Return 7/8 Partial Safe 2

DOCS Doximity, Inc. 87 Profit Growth Debt Cash Flow Return 5/8 Partial Safe 3

HRMY Harmony Biosciences Ho… 87 Profit Growth Debt Cash Flow Return 5/9 Safe 4

RMD ResMed Inc. 86 Profit Growth Debt Cash Flow Return 7/9 Safe 5

ISRG Intuitive Surgical, In… 85 Profit Growth Debt Cash Flow Return 7/8 Partial Safe 6

IRMD IRADIMED CORPORATION 85 Profit Growth Debt Cash Flow Return 5/8 Partial Safe 7

IDYA IDEAYA Biosciences, In… EmergingCheck EarningsData Issue 84 Cash Dil R&D RevPS Burn BalSh 3/7 Partial Safe 8

STOK Stoke Therapeutics, In… EmergingCheck EarningsData Issue 83 Cash Dil R&D RevPS Burn BalSh 4/7 Partial Safe 9

INVA Innoviva, Inc. Check EarningsData Issue 83 Profit Growth Debt Cash Flow Return 5/9 Safe 10

VEEV Veeva Systems Inc. 80 Profit Growth Debt Cash Flow Return 5 of 6 6/8 Partial Safe 11

EXEL Exelixis, Inc. 80 Profit Growth Debt Cash Flow Return 6/8 Partial Safe 12

HNGE Hinge Health, Inc. Emerging 80 Cash Dil R&D RevPS Burn BalSh 4/7 Partial Safe 13

ADMA ADMA Biologics, Inc. Check Earnings 80 Profit Growth Debt Cash Flow Return 5/9 Safe 14

ANAB AnaptysBio, Inc. EmergingCheck EarningsData Issue 80 Cash Dil R&D RevPS Burn BalSh 5/7 Partial Safe 15

NBIX Neurocrine Biosciences… 79 Profit Growth Debt Cash Flow Return 4/8 Partial Safe 16

NUTX Nutex Health Inc. One-time Loss 79 Profit Growth Debt Cash Flow Return 7/9 Safe 17

REGN Regeneron Pharmaceutic… 78 Profit Growth Debt Cash Flow Return 4/7 Partial Safe 18

HALO Halozyme Therapeutics,… 78 Profit Growth Debt Cash Flow Return 5/9 Safe 19

ARWR Arrowhead Pharmaceutic… EmergingCheck EarningsData Issue 78 Cash Dil R&D RevPS Burn BalSh 4/7 Partial Safe 20

GMAB Genmab A/S 77 Profit Growth Debt Cash Flow Return 3/8 Partial Safe 21

GMED Globus Medical, Inc. 77 Profit Growth Debt Cash Flow Return 8/8 Partial Safe 22

PTGX Protagonist Therapeuti… EmergingData Issue 77 Cash Dil R&D RevPS Burn BalSh 3/7 Partial Safe 23

CORT Corcept Therapeutics I… 77 Profit Growth Debt Cash Flow Return 4/8 Partial Safe 24

ZYME Zymeworks Inc. EmergingData Issue 77 Cash Dil R&D RevPS Burn BalSh 4/7 Partial Safe 25

IMCR Immunocore Holdings pl… EmergingData Issue 77 Cash Dil R&D RevPS Burn BalSh 5 of 6 3/8 Partial Distress 26

WST West Pharmaceutical Se… 76 Profit Growth Debt Cash Flow Return 7/9 Safe 27

LMAT LeMaitre Vascular, Inc… 76 Profit Growth Debt Cash Flow Return 7/9 Safe 28

COLL Collegium Pharmaceutic… One-time Loss 76 Profit Growth Debt Cash Flow Return 5/9 Distress 29

IDXX IDEXX Laboratories, In… 75 Profit Growth Debt Cash Flow Return 8/9 Safe 30

INCY Incyte Corporation 75 Profit Growth Debt Cash Flow Return 5 of 6 6/8 Partial Safe 31

BMRN BioMarin Pharmaceutica… 75 Profit Growth Debt Cash Flow Return 5/9 Safe 32

MDXG MiMedx Group, Inc. Data Issue 75 Profit Growth Debt Cash Flow Return 5/9 Safe 33

ARVN Arvinas, Inc. EmergingCheck EarningsData Issue 75 Cash Dil R&D RevPS Burn BalSh 4/8 Partial Distress 34

CBIO Crescent Biopharma, In… EmergingData Issue 75 Cash Dil R&D RevPS Burn BalSh 4/6 Partial Safe 35

DXCM DexCom, Inc. 74 Profit Growth Debt Cash Flow Return 7/9 Safe 36

TECH Bio-Techne Corporation 74 Profit Growth Debt Cash Flow Return 7/9 Safe 37

PODD Insulet Corporation 74 Profit Growth Debt Cash Flow Return 6/9 Safe 38

BFLY Butterfly Network, Inc… EmergingData Issue 74 Cash Dil R&D RevPS Burn BalSh 5 of 6 3/7 Partial Safe 39

CRON Cronos Group Inc. EmergingCheck EarningsData Issue 74 Cash Dil R&D RevPS Burn BalSh 6/8 Partial Safe 40

RIGL Rigel Pharmaceuticals,… Check EarningsData Issue 74 Profit Growth Debt Cash Flow Return 5 of 6 6/9 Safe 41

VRTX Vertex Pharmaceuticals… 73 Profit Growth Debt Cash Flow Return 6/8 Partial Safe 42

EW Edwards Lifesciences C… 73 Profit Growth Debt Cash Flow Return 6/9 Safe 43

TXG 10x Genomics, Inc. Emerging 73 Cash Dil R&D RevPS Burn BalSh 4/8 Partial Safe 44

ALKS Alkermes plc 73 Profit Growth Debt Cash Flow Return 5/8 Partial Safe 45

BCRX BioCryst Pharmaceutica… Data Issue 73 Profit Growth Debt Cash Flow Return 7/9 Grey 46

SDGR Schrödinger, Inc. Emerging 73 Cash Dil R&D RevPS Burn BalSh 5 of 6 4/7 Partial Grey 47

KURA Kura Oncology, Inc. EmergingCheck EarningsData Issue 73 Cash Dil R&D RevPS Burn BalSh 2/8 Partial Distress 48

INMD InMode Ltd. 73 Profit Growth Debt Cash Flow Return 3/8 Partial Safe 49

ZTS Zoetis Inc. 72 Profit Growth Debt Cash Flow Return 6/9 - 50

TVTX Travere Therapeutics, … EmergingCheck EarningsData Issue 72 Cash Dil R&D RevPS Burn BalSh 7/9 Safe 51

UFPT UFP Technologies, Inc. 72 Profit Growth Debt Cash Flow Return 7/9 Safe 52

FDMT 4D Molecular Therapeut… EmergingCheck EarningsData Issue 72 Cash Dil R&D RevPS Burn BalSh 3/7 Partial Safe 53

MDGL Madrigal Pharmaceutica… EmergingCheck EarningsData Issue 71 Cash Dil R&D RevPS Burn BalSh 3/8 Partial Safe 54

LNTH Lantheus Holdings, Inc… Check Earnings 71 Profit Growth Debt Cash Flow Return 5/9 Safe 55

MIRM Mirum Pharmaceuticals,… EmergingData Issue 71 Cash Dil R&D RevPS Burn BalSh 5/8 Partial Safe 56

AGIO Agios Pharmaceuticals,… EmergingCheck EarningsData Issue 71 Cash Dil R&D RevPS Burn BalSh 2/8 Partial Safe 57

JANX Janux Therapeutics, In… EmergingData Issue 71 Cash Dil R&D RevPS Burn BalSh 2/7 Partial Safe 58

LLY Eli Lilly and Company Check Earnings 70 Profit Growth Debt Cash Flow Return 5 of 6 7/9 - 59

WAT Waters Corporation 70 Profit Growth Debt Cash Flow Return 4/9 Safe 60

TCMD Tactile Systems Techno… 70 Profit Growth Debt Cash Flow Return 7/8 Partial Safe 61

ABT Abbott Laboratories 69 Profit Growth Debt Cash Flow Return 5/9 Safe 62

NVO Novo Nordisk A/S 69 Profit Growth Debt Cash Flow Return 4/8 Partial Safe 63

ENSG The Ensign Group, Inc. 69 Profit Growth Debt Cash Flow Return 5 of 6 5/9 Safe 64

LGND Ligand Pharmaceuticals… 69 Profit Growth Debt Cash Flow Return 4/7 Partial Safe 65

PGNY Progyny, Inc. 69 Profit Growth Debt Cash Flow Return 5/8 Partial Safe 66

NVS Novartis AG 68 Profit Growth Debt Cash Flow Return 8/9 - 67

PEN Penumbra, Inc. 68 Profit Growth Debt Cash Flow Return 6/8 Partial Safe 68

IONS Ionis Pharmaceuticals,… Emerging 68 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 69

MMSI Merit Medical Systems,… 68 Profit Growth Debt Cash Flow Return 7/9 Safe 70

VCYT Veracyte, Inc. 68 Profit Growth Debt Cash Flow Return 7/8 Partial Safe 71

ACAD Acadia Pharmaceuticals… Check Earnings 68 Profit Growth Debt Cash Flow Return 5/8 Partial Safe 72

VRDN Viridian Therapeutics,… EmergingCheck EarningsData Issue 68 Cash Dil R&D RevPS Burn BalSh 2/7 Partial Safe 73

ADUS Addus HomeCare Corpora… 68 Profit Growth Debt Cash Flow Return 7/9 Safe 74

ANIP ANI Pharmaceuticals, I… 68 Profit Growth Debt Cash Flow Return 7/9 Grey 75

AMPH Amphastar Pharmaceutic… 68 Profit Growth Debt Cash Flow Return 6/9 Grey 76

PBYI Puma Biotechnology, In… Check EarningsData Issue 68 Profit Growth Debt Cash Flow Return 7/9 Distress 77

ROIV Roivant Sciences Ltd. EmergingData Issue 67 Cash Dil R&D RevPS Burn BalSh 0/7 Partial Safe 78

RGEN Repligen Corporation 67 Profit Growth Debt Cash Flow Return 7/9 Safe 79

HQY HealthEquity, Inc. 67 Profit Growth Debt Cash Flow Return 9/9 Safe 80

ADPT Adaptive Biotechnologi… Emerging 67 Cash Dil R&D RevPS Burn BalSh 5/9 Safe 81

NHC National HealthCare Co… 67 Profit Growth Debt Cash Flow Return 7/8 Partial Safe 82

NAMS NewAmsterdam Pharma Co… EmergingData Issue 67 Cash Dil R&D RevPS Burn BalSh 2/7 Partial Safe 83

AUPH Aurinia Pharmaceutical… Check EarningsData Issue 67 Profit Growth Debt Cash Flow Return 5 of 6 6/8 Partial Safe 84

VIR Vir Biotechnology, Inc… EmergingData Issue 67 Cash Dil R&D RevPS Burn BalSh 3/8 Partial Grey 85

GLUE Monte Rosa Therapeutic… EmergingCheck Earnings 67 Cash Dil R&D RevPS Burn BalSh 4/7 Partial Grey 86

BBNX Beta Bionics, Inc. EmergingCheck EarningsData Issue 67 Cash Dil R&D RevPS Burn BalSh 4/8 Partial Safe 87

SENS Senseonics Holdings, I… EmergingData Issue 67 Cash Dil R&D RevPS Burn BalSh 7/9 Distress 88

SYK Stryker Corporation 66 Profit Growth Debt Cash Flow Return 4/9 Safe 89

A Agilent Technologies, … 66 Profit Growth Debt Cash Flow Return 5/9 Safe 90

BIIB Biogen Inc. 66 Profit Growth Debt Cash Flow Return 4/9 - 91

STE STERIS plc 66 Profit Growth Debt Cash Flow Return 9/9 Safe 92

RYTM Rhythm Pharmaceuticals… EmergingData Issue 66 Cash Dil R&D RevPS Burn BalSh 5/9 Safe 93

TNGX Tango Therapeutics, In… EmergingCheck EarningsData Issue 66 Cash Dil R&D RevPS Burn BalSh 3/7 Partial Safe 94

NTLA Intellia Therapeutics,… EmergingData Issue 66 Cash Dil R&D RevPS Burn BalSh 2/7 Partial Distress 95

JNJ Johnson & Johnson 65 Profit Growth Debt Cash Flow Return 3/9 - 96

ALC Alcon Inc. 65 Profit Growth Debt Cash Flow Return 6/9 - 97

XENE Xenon Pharmaceuticals … EmergingData Issue 65 Cash Dil R&D RevPS Burn BalSh 5 of 6 2/7 Partial Safe 98

ZLAB Zai Lab Limited EmergingData Issue 65 Cash Dil R&D RevPS Burn BalSh 3/8 Partial Distress 99

LXRX Lexicon Pharmaceutical… EmergingCheck EarningsData Issue 65 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 100

MRK Merck & Co., Inc. 64 Profit Growth Debt Cash Flow Return 4/9 -

How the Financial Health Score is calculated

Each company receives a composite score from 0 to 100 built from six dimensions derived from SEC filings. The dimensions are family-specific: a company is scored on the metrics that matter for its business type, then ranked against direct peers rather than across every industry. A score is a company's standing within its peer group, not an absolute cross-industry rating; a 70 for a bank and a 70 for a software company both mean "top of its family," not "equally strong businesses."

Each of the six dimensions is scored as a percentile within the family (how the company ranks against its peers on that dimension). The overall score is the rounded average of the dimensions we can compute from the company’s filings, so when one of them cannot be measured the score averages the other five, and the table marks it 5 of 6. We rank a company only when at least five of its six dimensions can be computed.

Operating companies, energy and utilities are scored on Profitability, Growth, Leverage, Liquidity, Cash Flow, and Returns.
Banks are scored on Earnings, Growth, Capital, Efficiency, Credit Quality, and Stability.
Insurers are scored on Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, and Stability.
REITs are scored on FFO Margin, FFO Growth, Leverage, Interest Coverage, AFFO Margin, and Dividend Coverage.
Emerging (pre-profit) companies are scored on Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, and Balance Sheet.
Warrants, preferred shares, notes and duplicate listings that share a parent company's financials are automatically filtered from the ranking.
Only companies with a market value of at least $500 million that are still trading are ranked.

The Piotroski F-Score (0 to 9) measures fundamental strength using nine binary accounting tests; the Altman Z-Score estimates bankruptcy risk, classifying companies into Safe, Grey, or Distress zones. These two signals are shown alongside the composite score for additional perspective. When the filings cannot support all nine tests, the F-Score is shown out of the tests that could be run and marked Partial.